ESMO Young Oncologists: we are now accepting applications for our Translational Research and Clinical Research fellowships. Apply today!
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
ESMO’s flagship scientific journal, Annals of Oncology, publishes editorials, reviews, original articles and letters related to oncology
Our open access, online journal, ESMO Open is now listed in Pubmed Central, only 10-months after launch. Learn more about the journal!
Fortunato Ciardiello reflects on his first year as President of ESMO and looks at the milestones the society reached in 2016.
16 Jan 2017
Four bursaries will be awarded to assist ESMO members to attend the training course
16 Jan 2017
Second priority review granted for atezolizumab in advanced bladder cancer
13 Jan 2017
EMA’s pilot project to commence in February 2017
12 Jan 2017
It is recommended in adults who have had at least one chemotherapy and targeted treatment if they have an EGFR- or ALK‑positive tumour
10 Jan 2017
Matching patients with three molecular groups to phase II clinical trials to explore the safety, tolerability and efficacy of the medication for each...
09 Jan 2017
It concerns the treatment of patients with HER2-positive, locally advanced, inflammatory or early-stage breast cancer at high risk of recurrence
03 Mar - 03 Mar 2017
03 Mar - 05 Mar 2017
16 Mar - 18 Mar 2017
Sitges, Barcelona, Spain
17 Mar - 18 Mar 2017
04 May - 06 May 2017
05 May - 08 May 2017